Back to results
US 11,629,367 B2Granted
Systems and methods for production of recombinant IL-11 in yeast
AssigneeNansha Biologies (HK) Limited
InventorsQui-Lim Choo, Manson Fok, Johnson Yiu-Nam Lau
Life of this patent
Estimating the term…
Abstract
Recombinant interleukin-11 (rhIL-11) is expressed in yeast, then isolated from aerobic fermentation media by precipitation, solubilization of the precipitate in the presence of a denaturant, and renaturation of the solubilized protein. Renatured rhIL-11 is further purified by cation exchange and hydrophobic interaction chromatography to provide a highly purified rhIL-11 with high biological activity and low rhIL-11 dimer and oxidized rhIL-11 content.
Claims11
A method for producing interleukin 11 (IL-11), comprising:
- introducing an expression vector encoding for a recombinant IL-11 into a yeast, wherein the recombinant IL-11 is not in the form of a fusion protein;
- culturing the yeast in a culture media under conditions to induce expression of IL-11;
- following culturing of the yeast, removing solids from the culture media to produce a supernatant;
- contacting the supernatant with a polyethylene glycol having an average molecular weight of about 2,000 D to about 20,000 D in quantities sufficient to form a suspension comprising a precipitate, wherein the polyethylene glycol is present in the supernatant at from about 4% (w/v) to about 12% (w/v) after contacting;
- collecting the precipitate;
- solubilizing the precipitate in a solution comprising guanidine hydrochloride at a concentration of about 4M to 10M to produce a crude IL-11 solution;
- reducing the guanidine hydrochloride concentration to 0.7M or less at a pH of about 4 to about 12 and at an IL-11 concentration of 0.1 mg/ml to 10 mg/mL to produce a refolded IL-11 solution;
- contacting the refolded IL-11 solution with a cation exchange media;
- and
- eluting a purified IL-11 from the cation exchange media.
7 more elements
Dependencies are inferred from the claim text.